From: PACAP–Sirtuin3 alleviates cognitive impairment through autophagy in Alzheimer’s disease
Total (n = 45) | Control group (n = 20) | AD group (n = 25) | P value | |
---|---|---|---|---|
Age (years) | 62.53 ± 9.68 | 58.25 ± 8.88 | 65.96 ± 9.04 | 0.006* |
Sex, n (%) Female | 26 (57.78%) | 11 (55.00%) | 15 (60.00%) | 0.739 |
Education (years) | 12.00 ± 3.84 | 12.25 ± 3.45 | 11.80 ± 4.18 | 0.847 |
PiB PET-CT, n (%) (positive) | 25 (55.6%) | 0 (0.00%) | 25 (100%) | < 0.001* |
CDR Global Score | 0.71 ± 0.87 | 0.00 ± 0.00 | 1.28 ± 0.79 | < 0.001* |
Blood biomarkers | ||||
PACAP | 5.51 ± 2.06 | 7.46 ± 1.41 | 3.94 ± 0.70 | < 0.001* |
MAP1LC3B | 0.063 ± 0.054 | 0.087 ± 0.067 | 0.043 ± 0.028 | 0.003* |
Aβ42 | 10.26 ± 3.18 | 11.71 ± 3.69 | 9.38 ± 2.52 | 0.028* |
pTau | 4.91 ± 2.71 | 3.51 ± 2.09 | 5.82 ± 2.72 | 0.004* |
Tau | 3.44 ± 1.57 | 3.30 ± 1.57 | 3.62 ± 1.60 | 0.552 |